ArticlePDF Available

Abstract

Background: Various methods were introduced to overcome the autograft shortage in burn wound care, including cell transplantation and tissue engineering. Aims: To evaluate the healing effect of allogenic human Wharton's jelly stem cells (hWJSCs) seeded onto acellular dermal matrix (ADM) in rat burn injuries. Patients and methods: Human Wharton's jelly stem cells provided from umbilical cord tissue were characterized before transplantation, and the growth kinetic was determined. Skin samples from cosmetic surgeries were used for preparation of ADM. Forty male Sprague Dawley rats were randomly divided into 4 equal groups. Third-degree burn was induced for all animals by exposing to hot water using a 2 cm ring for 10 seconds. Group 1 was burned rats that did not receive any treatment. After burn injury, the second group received silver sulfadiazine (SSD), the third group was treated just by using ADM, and the fourth group received 2 × 106 hWJSCs seeded onto ADM. The animals were euthanized for histologic evaluation after 7, 14, and 21 days. Results: Human Wharton's jelly stem cells were characterized to be spindle shape and positive for osteogenic and adipogenic induction and for mesenchymal markers but lacked hematopoietic markers. Population doubling time (PDT) was 40.1 hours with an increasing growth trend until day 6th. Macro- and microscopically, the healing was mild in ADM group and moderate in ADM + hWJSCs group after 21 days. Conclusion: Allogenic hWJSCs seeded onto ADM improved the healing process in burn wounds denoting to their therapeutic and anti-inflammatory effects in burn wounds that can be added to the literature.
J Cosmet Dermatol. 2019;00:1–7. wileyonlinelibrary.com/journal/jocd  
|
 1
© 2019 Wiley Periodicals, Inc.
Received:24April2019 
|
  Revised:2 0July2019 
|
  Accepted:23July2019
DOI:10.1111/jocd.13109
ORIGINAL CONTRIBUTION
The effect of allogenic human Wharton's jelly stem cells
seeded onto acellular dermal matrix in healing of rat burn
wounds
Mehra Nazempour MSc1| Davood Mehrabani PhD2,3,4,5 |
Rouhollah Mehdinavaz‐Aghdam PhD6| Seyedeh‐Sara Hashemi PhD3|
Amin Derakhshanfar PhD4| Shahrokh Zare MSc2| Mitra Zardosht MSc3|
Javad Moayedi MSc4| Mahjoob Vahedi DVM4
1Depar tmentofBiomedicalandTissue
Enginee ring,S ciencea ndResearch
Branch,IslamicAzadUniver sity,Tehran,Iran
2StemcellTechnologyResearch
Center,Shir azUnive rsityofMedic al
Science s,Shir az,Iran
3BurnandWoundHealingRese arch
Center,Shir azUnive rsityofMedic al
Science s,Shir az,Iran
4Compar ativean dExpe riment alMedicine
Center,Shir azUnive rsityofMedic al
Science s,Shir az,Iran
5Depar tmentofPathol ogy,Unive rsityof
Alber ta,Edmonton,Alber ta,C anada
6SchoolofMetallurgya nd
MaterialsEngine ering ,Collegeof
Enginee ring,U niversityofTehran,Tehran,
Iran
Correspondence
DavoodMehrabani,StemcellTechnolog y
ResearchCenter,Shi razUniversit yof
MedicalSciences,Shiraz,Ir an.
Email:mehrabad@sums.ac.ir
Rouholl ahMehdinavaz‐Aghdam,S chool
ofMetallurgyandMater ialsEngineering,
CollegeofEnginee ring,U niversityofTehran,
Tehran,Iran.
Email:mehdinavaz@ut.ac.ir
Funding information
Nationa lInstituteforMedicalResearch
Develop mentofIr anMinis tryofH ealth ,
TreatmentandMedic alEducation,G rant/
AwardNumber:963 474
Abstract
Background: Variousmethodswereintroducedtoovercometheautograftshortage
inburnwoundcare,includingcelltransplantationandtissueengineering.
Aims: Toevaluatethe healing effect of allogenic human Wharton's jellystem cells
(hWJSCs)seededontoacellulardermalmatrix(ADM)inratburninjuries.
Patients and Methods: Human Wharton's jell y stem cells provided f rom umbilical
cord tissue were characterized before transplantation, and the growth kinetic was
determined. Skin samples from cosmetic surgeries were used for preparation of
ADM.FortymaleSprague Dawley ratswererandomly dividedinto4 equalgroups.
Third‐degreeburnwasinducedforallanimalsbyexposingtohotwaterusinga2cm
ring for 10seconds. Group1 was burnedratsthat did not receive any treatment.
Afterburninjur y,thesecondgroupreceivedsilversulfadiazine(SSD),thethirdgroup
was treated jus t by using ADM, and the four th group received 2 × 106 hWJSC s
seededontoADM.Theanimalswereeuthanizedforhistologicevaluationafter7,14,
and21days.
Results: HumanWharton'sjelly stem cells were characterizedto be spindle shape
andpositiveforosteogenicandadipogenicinductionandformesenchymalmarkers
butlacked hematopoietic markers. Population doubling time (PDT)was 40.1 hours
withanincreasinggrowthtrenduntilday6th.Macro‐andmicroscopically,theheal‐
ingwasmildinADMgroupandmoderateinADM+hWJSCsgroupafter21days.
Conclusion: Allogenic hWJSCs seeded ontoADM improved thehealingprocessin
burn wounds d enoting to their ther apeutic and anti‐inflam matory effec ts in burn
woundsthatcanbeaddedtotheliterature.
KEY WORDS
acellulardermalmatrix,burn,healing,Wharton'sjellystemcells,wound
2 
|
   NAZEMPOUR Et A l.
1 | INTRODUCTION
Burnisresponsibleforabout265000globaldeathsperyearandis
stilloneofthemosttraumaticinjuriesworldwidewithpublichealth
concernleadingtosocialandeconomicconsequences.1Burninjury
ischaracterizedbydestructionofskinstructures,functions,andloss
of progenito r cell populat ions that are nec essary fo r regeneratio n
andrestorationof the skin.Burnwoundscandelayanddisruptthe
cic at rici alprocesses,andin creasethech an ce soffu nc tional an daes
thetic se quelae and ar e responsible f or formation of sc ar and ke‐
loidduetoscarcontractureanduncontrollableproliferationofscar
tissue.2
Therefo re, an effecti ve wound manageme nt has an import ant
roleinburntherapyfor timelyandpermanentclosure offull‐thick‐
ness burnwounds. Graftingtechniques such as split‐thicknessand
full‐thickness graftsarewelldevelopedto improvetheappearance
and function of the lesions, eventhe effectiveness of thesemeth‐
ods is limite d because of t he availabilit y of donor ski n in patients
with large total body surface area (TBSA) burns, and the fact that
burn patients may experience a significant delayinwoundclosure,
infection,scarring,anddeath.3Toovercometheautograftshortage
in burn wou nd care, var ious alternat ive methods we re introduce d
including allogeneic and synthetic skin substitutes and xenograf ts,
eventheyaretemporar yforwoundcoverageanddeliverdifferent
bio‐factorstofacilit atethe angiogenesis and granulationof wound
bedforfurthersurgery.4
Burninjurycan bedeepenedbyinfection,andtherebyincrease
thetotaltissuedamageandtheriskofcomplicationssuchashyper
trophicscarring.5 Soitisnecessarytodevelopadjuvanttreatments
withantimicrobialpropertiessuchassilversulfadiazine(SSD).6 SSD
hasbeen introduced asagoldstandardwithanenviable safety re‐
cord in bur n treatment with an timicrobial prop erties, but i ts side
effects suchas leukopenia werereported as disadvantages of this
medication.7 In past d ecades, cell t ransplant ation has emerge d as
anoth er po pu la roptionfo rimprovedburnwou ndhealingan dregen
erationofskinstructureandfunc tions.8
Thetherapeuticroleofmesenchymalstemcells(MSCs)inheal
ing is the topic of interest, because they have the ability to differ‐
entiate into mesodermal, ectodermal, and endodermal cells with
lowimmunogenicity and paracrine activities.8 MSCs were isolated
from varioustissuesincludingbone marrow,9adipose tissue,10 and
dentalpulp.11They are easily cultured and grown, take more time
tobecome senescent andexpressMSCmarkers,and lack hemato‐
poieticmarkers.12The transplantationofMSCsinburninjuries was
demonstrated toimprovescarqualityby earlyclosureof thelesion
andto promoteregenerationoftheskinanditsappendagesandto
attenuatetheinflammatoryprocess.13
The Whar ton's jelly‐like matrix of the umbilical cord is a rich
sourceofMSCscalledWharton'sjellystemcells(WJSCs)thathave
a high immun omodulator y activity, simil ar to bone marrow MS Cs
(BM‐MSCs).Currently,WJSCs have clinical application for a broad
scope of diseases.14 Human Wharton's jelly stem cells (hWJSCs)
haveproper tiessuchasrobustproliferationanddifferentiation,and
weak immunogenicit y,thereby posing a great potential in thefield
ofregenerativemedicine.15MSCscanbeseededontoseveralscaf
folds prov iding a three‐d imensional env ironment for th e MSCs to
grow and improvethe reconstruction of the injuredtissues.These
scaffoldswereshowntopossessproper ties such asporosit y,cyto‐
compatibility,biodegradability,surfacephysicochemical,andbiome
chanicalactivities.16
Tissue engineering by using MSCs seeded onto the scaffolds
aimstooptimizetheaestheticandfunctionalreconfigurationofthe
skin with t he potential in t reatment of bur n injuries, wou nd heal‐
ing, skin regeneration, reducing inflammatory responses, and im
provingsc arring.17G reat advance s in dermal sca ffolds resul ted in
introductionofacellulardermalmatrix(ADM)tobeextensivelyused
inreconstructivesurgery.18Itisapopulardermal scaffoldmaterial
commonlyusedfortreatmentofburninjuries.19
It was first introduced in 1995 in treatment of full‐thickness
burninjuries20 andlaterinotherclinicalsettingstorepairwounds.
Several surgeonshave startedcollaboration inordertoincorporate
tissueengineeringandstemcellsasanefficacioustreatmentoption
withthehope tobeimplementedwithlowrisk, lowmorbidity,and
withmorebenefitsoverconventionaltreatment.17, 19 Therearesev
eral challenges to the use of stemcellsalone in burninjuries to be
adminis tered topic ally or intr avenously. This s tudy was cond ucted
toevaluate the healing effect of allogenichWJSCsseeded onto an
ADMscaf foldinburninjuriesinexperimentalratmodel.
2 | SUBJECTS AND METHODS
2.1 | Animals
Forty male Sprague Dawley rats (180‐200 g) purchased from
Laboratory AnimalCenterofShirazUniversityof MedicalSciences,
Shiraz, Iranwereenrolled. The animalswerekept singlein cagesat
controlledtemperature (22.0±2.0°C) and lighting (12hours light/
darkcycles)andhadfreeaccesstofoodandwater.Ketamine(5mg/
kg;Woerden, Netherlands)andxylazine(20mg/kg;Alfaz yne)were
usedintraperi toneallytoa nesthet izetheanima lsd uringallinter ven
tions. Pos tburn analge sia was provided b y subcutaneo us adminis‐
tration of 0.0 5 mg/kg bupre norphine, th ree times dail y (Produlab
Pharma) until sacrifice. Throughout the experiment,any changesin
theskin, complications and infection were recorded.Therats were
euthani zed after 7, 14, and 21 days po stintervent ions. All expe ri‐
mentswereundertakenbasedonIranVeterinar yOrganizationrules
andregulationsforworkingwithlaboratoryanimals.Thisstudywas
financi ally suppor ted and ethica lly approved by Nat ional Institu te
for Medical Research Development of Iran Ministry of Health,
TreatmentandEducation(Grantno.of963474).
2.1.1 | Isolation of hWJSCs
HumanWhar ton'sjellystemcellswereprovidedfromumbilicalcord
tissuebyenzymaticdigestion asdescribedbefore.14Briefly,umbili
calcordsamples(n=3)wereprovidedfromhealthyvolunteersafter
    
|
 3
NAZEMP OUR Et A l.
receiptofaconsentletter.TheywereasepticallytransferredtoBurn
andWoundHealingResearchCenterofShirazUniversityofMedical
Sciences,Shiraz,Iraninphosphatebuffersaline(PBS:Sigma‐Aldrich)
containingpenicillin, streptomycin,andamphotericin B(100U/mL,
100µg/mL,and0.25µg/mL,respectively;Invitrogen).After3times
washing with Hanks' balanced saltsolution (Invitrogen), theywere
horizontally cut into1‐cm pieces with eachpiece cut open length‐
wiseandplacedwithitsinnersurfacefacedownintoenzymaticso
lution consistedof collagenase typeI,collagenase typeIV(Thermo
FisherScientific),andhyaluronidase(Sigma‐Aldrich).
Theywerelatertransferredin5%CO2incubatorat37°Candsat
uratedhumidity for 45 minutes. The enzymaticsolution resulted in
dissolve d gelatinous mas ses of Wharto n'sj elly. It was then filt ered
th r o u gha s y r i nge o f18 gaug e n eedl e t ofu r th e r brea k u pthe r e main e d
ge l a tino u s mass e s a ndt o f a cil i t a tet h e r elea s e ofc e l lsf r o mthe m a sses.
Itwascentrifuged,and the viablecellswere plated at a densityof1
millioncells/cm2in100‐mmcellculturedishesadding90%Dulbecco's
ModifiedEagle'sMedium/F12(DMEM/F12,Invitrogen)with10%FBS
(Gibco), 1%nonessential amino acids (Invitrogen), 2 mmol/L L‐gluta
mine, (Invitrogen) and1%penicillin, streptomycin, andamphotericin
B. Afte r 5 days, the medium w as replaced and s ubsequent cult ure
mediawaschangedevery3day s.T headhere ntcell sweretransferred
to5%CO2incubatorat37°Candsaturatedhumidity.Cellcounting
wasconduc tedusingtrypanbluedyeandNeobarhemocytometer.
2.2 | Characterization of WJSCs
Human Wha rton's jelly s tem cells were ev aluated mor phologic ally
for being spindle shape. They were assessed for in vitro osteo‐
genic induction seeding 5 × 104WJSCsina12‐wellplatecontain
ingDMEM, supplementedwith 10% FBS, and osteogenicmedia of
200 μmol/L L‐ascorbicacid (Sigma),10 mmol/L glycerolphosphate
(Sigma),and100nmol/Ldexamethasone(Sigma).Themediawasre‐
placed for 3 weeks every3days. The dif ferentiation was assessed
byalizarinredstaining(Sigma)thatis boundtocalciummineralized
depositsandrevealingaredcolor.
Toevaluate in vitroadipogenicproper ty,5× 104 hWJSCswere
seeded i n a 12‐well plate in DMEM supp lemented wit h 10% FBS,
containingadipogenic medium of 1 μmol/L dexamethasone,5μg/
mLinsulin(Sigma),0.5mmol/Lisobutylmethylxanthine(Sigma),and
60 μmol/Lindomethacin(Sigma)for21days,whilethemediumwas
changed every 3 days. The cells were later stained with Oil red O
(Sigma) revealing red color droplets. Flow c ytometry was under‐
taken on 3rdpassageofhWJSCstoassess the expression of mes‐
enchymal surface markers for CD73 and CD90 and hematopoietic
surfacemarkersofCD34,andCD45(Dako,Denmark).
2.3 | Growth kinetics
Atotalof4×104hWJSCsfrompassage3seededin24‐wellculture
platesweretransferredin5%CO2incubatorat37°Cand saturated
humidity,while the media was changed every3days. Cellviabilit y
wasevaluated eachdayfor7 days using 0.4% tr ypan bluesolution
(Biowest ), a Neubauer hem ocytomet er slide and a phas e contrast
microscope. The population doubling time (PDT) was determined
by plotting the grow th curve and using the formula of PDT = T
ln2 = ln(Xe/Xb); while T was incubationtime in hours, Xb was cell
numberatthebeginningofincubationtime,andXewascellnumber
attheendoftheincubationtime.Themeannumberofcellsateach
time point wasplottedusing GraphPadPrism (GraphPad Software
Inc).Cellswerecr yop re ser vedata de nsityof 1×106c ells/mLin10 %
dimethyl sulphoxide (DMSO;MPBio USA) (V/V),50% fetalbovine
serum(V/V),and40%DMEM.
2.4 | Acellular dermal matrix (ADM) preparation
The human s kin sampl es were asepti cally pre pared from co smetic
surgeries of Depar tment of Plastic Surgery, Shiraz University of
Medica l Sciences, S hiraz, and t ransfer red to Stem Cell L aborator y
of Burn and Wound Healing Research Center af filiated to Shiraz
University of Medical Sciences. The tissue samples were kept in
PBS, whil e penicillin‐s treptomycin an d fungisone wer e added. For
washing,0.5%TritonX‐10 0and10mmol/LEDTA(Sigma)wereused
2times.Allepidermal,fattissues,andhairswereseparated,andthe
re m a i n e dtis s u e w ask e p tat −2 0 ° C u n t ilu s e . To remov e e pide r m a l t is
sue,1MNaCl,0.5%TritonX‐100and10mol/LEDTAsolutionwere
appliedinashakingincubatorat37°Cfor24hours.Decellularization
wasconduc tedusing0.5%sodiumdodecylsulfate(SDS),10mmol/L
HEPES, an d 10m mol/L EDTAso lutions (Sigm a)i n an incubator at
37°C for 1 ho ur.Be fore lyophiliz ation, peni cillin‐str eptomycin and
fungisonewereaddedtothesolution.
2.5 | Experimental design
FortymaleSprague Dawley 180‐200g ratswererandomly divided
into 4 equal g roups. Third‐ degree burn i nduction w as undert aken
for all anim als by exposin g to hot water using a 2 cm ring for t en
seconds.InGroup1,ratswereexposedtohotwaterfor10seconds,
without a ny treatment meas ure. The second gro up received SSD
ointment after burn induc tion, the thirdgroup wastreated just by
ADM scaffold, andt hefour thgroup underwent treatment by cell
tra nspla ntationof2×10 6hWJSC sseed edontoADMsc af fold.After
treatment,theanimalswereeuthanizedformacroscopicandhisto
logicevaluation.
2.6 | Histologic assessment
Histolog ic assessment of A DM was done before l yophilization by
fix ationoftiss uesam plesi n4%buf fere dfo rmali n.Theywe resubse
quentlyembeddedinparaffin.Tissuesections(5micronsthickness)
wereprepared and stained withhematoxylin and eosin(H&E), and
Alcian bl ue. Skin sam ples were fi xed in 10% formali n and embed‐
dedinparaffin.Specimenswerelatersectioned(5μmthickness)and
dried over night at 37°C . Sectio ns were depar affinize d, rehydrate d
withagradedethanolseries,andstained withH&Eformicroscopic
evaluation(Olympus).
4 
|
   NAZEMPOUR Et A l.
3 | RESULTS
3.1 | Characterization of WJSCs
Morphologically,WJSCswere adherent to the culture flasks and
werespindleshape(Figure1).Theosteogenicinductionpropert y
ofthecells was confirmed by Alizarin red staining after3weeks
dueto the presenceofcalcium depositsinredcolorintheflasks
(Figure 1). Oi l Red O staining of WJSCs af ter 21 days revealed
adipogenicinduction of the cellsinred color droplets(Figure 1).
Under fl owcytometr y, th e cells were positive fo r expression of
mesenchymalmarkersincludingCD73andCD90,andwerenega
tiveforexpressionof hematopoieticmarkers ofCD34andCD45
(Figure1).
3.2 | Growth kinetics
PDT of the 3rd pas sage of hWJSCs for seven days was s hown in
Figure2revealingaPDTof40.1hours.Therewasanincreasingtrend
incellmultiplicationuntilday6,andthenadecreasewasnoticed.
FIGURE 1 HumanWhar ton'sjellystemcellsindifferentpassages.A,Passage1(40×),B,Passage2(40×),C,Passage3(40×),D,Control
inpassage3(40×).E,Osteogenicdif ferentiationofhWJSCsafter21dusingAlizarinRedstainingdenotingtopresenceofcalciumdeposits
indifferentiatedcells(40×).F,AdipogenicdifferentiationofhWJSCsafter3wkusingOilRedOstaining(40×).G,FlowcytometryofhWJSCs
showingthepositiveexpressionofmesenchymalmarkers(CD73andCD90)andthenegativeexpressionofhematopoieticmarkers(CD34
andCD45)
(A) (B) (C)
(D)
(G)
(E) (F)
    
|
 5
NAZEMP OUR Et A l.
3.3 | Histologic evaluation
Macroscopicallyingroup1 (leftuntreatedaf terburninjury),thele‐
sion size was 14.6%, d ecreased by 5 4.1%in g roup 2 (SSD group),
71.3%ingroup3(justADMscaffold),and87.6%ingroup4(hWJSCs
seededontotheADM).AsFigure3showsinADMsamples,H&E(A)
andAlcian blue(B)staining methodsconfirmed presenceofhyalu‐
ronicacid(acidicglycosaminoglycans)inthescaffolds.After3weeks
in group 1 (C), v asodilatio n, conjest ion, hemor rhage, infi ltration of
inflammatorycells,andextensivenecrosisandthelackofepidermal
layerwerenoted.
Ingroup2(D)receivingSSD,conjestion,infiltrationofinf lamma
torycells,andformationofgranulationtissuewerevisible.Ingroup
3(E)receivingADMalone,infiltrationoffewinflammatorycells,an
giogenesis, formation of granulation tissue, par tial epithelialization
revealing a m ild healing pro cess were obser ved. In group 4 usin g
WJSCsseededontoADM(F),angiogenesis,formationofgranulation
tissue, epithelialization revealing a moderate healing processwere
seen.
4 | DISCUSSION
Thefirstrepor tedapplicationofstemcelltherapyinburncare was
byShumakovetalin2003comparingallogenicandautologousBM‐
MSCswithembr yonicfibroblast sinburnwoundsof40ratsshowing
thatstemcelltransplantationcouldexpeditethewound healing.21
Their anti‐inflammatory, immunomodulatory, angiogenic, and re
generativeactivitiesinhealingofburnwoundsforskinandskinap‐
pendagewereillustratedlater,22whiletheycouldimprovet helevels
ofcollagendeposition,granulationtissue formationinburninjuries
too.23
Itwasshownthattheadministered dosageof MSCshasan im‐
por tantroleinef fi ca cyofce llthe ra pyofbu rnwounds.24Karim ietal
report edusing5×106adipose‐derivedstemcells(ADSCs)inhealing
ofacuteburninjuries.24Thetherapeuticefficacyofautologousand
allogenicADSCshasbeencomparedinhealingofacuteburninjuries
showing th at autologous st em cells were supe rior in wound hea l‐
ing.25Inou rs tud y,2 ×10 6all og enichWJ SC sse ede do nt oA DMinrat
burninjuriescouldacceleratewoundhealing.Ourfindingsweredif‐
ferent frompreviousrepor ts thatrevealedautologousMSCs were
superiortoallogenicstemcellsinwoundhealing.26
Inburn injuries,MSCs have been applied fromvarioussources
of autologous, allogeneic, or xenogeneic and in conjunction with
FIGURE 2 GrowthcurveandPDTofhWJSCs
FIGURE 3 HistologicevaluationofADMscaffoldbyA ,H&EandB,Alcianbluestaining.Blueregionsdenotetomatrixsecretion(Black
arrowsdenotetoglycosaminoglycans,400×).C,Group1receivednotreatmentafterburninductionshowingnecrosisandabsenceof
epidermallayerafter21d(40×).D,Group2receivedSSDafterburninductiondemonstratingnecrosis,inflammation,andformation
ofgranulationtissueafter3wk(40×).E,Group3whenjustADMwasappliedaf terburninductionrevealsangiogenesis,formationof
granulationtissue,andimprovedepithelializationleadingtoamildhealingprocessafter21d(40×).F,Group4thathWJSCswereseeded
ontoADMafterburninductiondisplayedepithelialization,angiogenesis,andformationofgranulationtissueresultinginamoderatehealing
process(40×)
(A) (B) (C)
(D) (E) (F)
6 
|
   NAZEMPOUR Et A l.
differentscaffolds.26Whenscaffoldswereaddedtocelltherapyin
burninjuries,afasterandbetterwoundhealingweredemonstrated.
Orbay et al s howed that ADSCs se eded onto ADM result ed in a
better implantforwoundvascularization,volumemaintenance,and
collagenquantity.27AftertopicalapplicationofBM‐MSCs together
with fibrin glue, anaccelerated burnhealing with skin appendages
wasseeninratswithscaldburns.28
In burn wou nds treated wit h ADSCs in conjun ction with atel o
collagen matrix with silicone membrane (ACMS), an advanced gran
ulationtissueandcapillaryformationwereobserved.29 Motamedet
al evaluate d regeneratio n of burn tissue us ing ADSCs see ded onto
the human a mniotic membr ane and noticed an a ccelerated woun d
healinginratswiththelowestinflammatorycellinfiltrateafter7and
14day s.30Inpor cin em ode lo fb urn injur y, BM‐ MC S sa nds ki n‐d eri ve d
keratino cytes in co njunction w ith human amni otic membra ne were
compared.Itwasshownthatthetransplantedcellscouldimproveep
ithelialization,angiogenesis,andthe amountsofcollagendeposition
andgranulationtissueandacceleratethehealingofthewound.31
Autologous ADSCs together with absorbable human cellular
collagenmatrixweredemonstratedto recruitendothelialcellsand
enhance formation of vascular network andimprove thetissue re‐
modeling and angiogenic dynamics, and increase the amount of
granulation tissue.32 Another study used ADSCs seeded onto a
collagen sc affold in b urn injur y and repor ted increas ed neovascu‐
larization,acceleratedmaturationof the wound,increased collagen
deposition,anddecreasedwoundbeddepthafterthreeweeks.33
Inour study,seedingofWJSCsontothe ADM scaffoldresultedin
animprovedangiogenesis, and granulation tissue formation, and de
creasedinflammation,necrosisandfibrosisafter21days.Similartoour
findings,an intensereductionininflammationand fibrosiswas exhib
it edw hen ADS C sw ere tran spl ant edi nbu rnw oun d s.34A ls oaf t ert r ans
plantationofMSCs, a reduction in necrosis (20%) in comparisonwith
thecontrolgroup(100%)wasdemonstratedinacuteburninjuries.35
Theanti‐inflammatoryroleofMSCsinburn skin tissues can be
explainedbydownregulationofinflammatorymarkers,upregulation
of anti‐inflammatory markers and a local increase in anti‐inflam
matory cytokines.36 The immunom odulatory effect of MSC s was
shown to be due to secretion of “secretomes”orextracellularves‐
icles tha t furthe r downregul ate the IL‐6 and nitric ox ide syntha se,
andi ncreasetheIL‐10andATP.37Liuetalbyintravenousapplication
ofhumanUC‐MSCson burn woundsofratsrepor tedadecreasein
inflammatorycellinfiltrates,interleukin‐1and6,andTNFalpha,and
ahigherratioofcollagentypesI/III,vascularization,neo‐angiogene
sis,andkeratinizationleadingtoafasterwoundhealing.38
Inourstudywh encomparingthelesi onsizein diff erentgr ou ps,
it was shown t hat in rats l eft untrea ted after bu rn injury, the l e
sionsizewas14.6%,thatdecreasedby 54.1% afterapplying SSD,
by71.3% afterusing ADM alone and by 87.6%when the animals
received WJSCs seeded onto the ADM. Similar to our findings
aftercreatingburninjuries,asignificantchangeinsizeoftheburn
woundwasnoted aftertransplantation ofADSCs (84.9%)in com
parisonwith the control group (69.7%).30Francketalreporteda
statisticallysignificantdecreaseintheburnsizewithtransplanted
ADSCs(40.4 4%)whencomparedwiththecontrolgroup(32.26%).2
InporcinemodelwithcontactburnsusingallogeneicMSCswitha
fibrinmatrix,astatisticallyreducedburnwoundsizewasnoted.39
There wereseveral limitations in our study including the use
oftheratmodel for studying human woundhealing as histologic
structuresandhealingcharacteristicsinhumanaredif ferentfrom
rats. A lso in rats, co ntraction p lays an impor tant role in woun d
healing , while in human, t he wound healing ha ppens by re‐epi
thelialization.Inrats,thepanniculuscarnosusplaysanimportant
role inwound contraction that was removedaf terdebridement
influenci ngo urr esult s.Thesecondlimit ationofourst udywasthe
number ofhWJSCs(2×106cells)thatwasusedthatwasinsmall
amountquantity,whilealargerquantit yof stem cellsseems nec
essary for celltherapyin burn patients. The third limitation was
the allogenic source of transplanted cellsthat maydecrease the
immunomodulating and anti‐inflammatory activities of hWJSCs
andthelastlimitationwastheduration ofsamplinguntil3weeks
thatmaynecessitatelongertimeintervalsupto1‐3months.
5 | CONCLUSION
Our findings showed that allogenic hWJSCs seeded onto ADM
couldimprovethehealingprocessdenotingtothetherapeuticef
fic ac yofWJSC sintreatme ntofac uteburni njuri es .Mo restudiesi n
smallandlargeanimalmodelswithlargerquantityofstemcellsand
duringalongertimeintervalareneededtodrawsolidconclusions.
ACKNOWLEDGMENTS
We would like to thank National Institute for Medical Research
Development of Iran Ministr y of Health, Treatment and Medical
Education(Grantno.of963474)forfinancialsupportandStemCell
TechnologyResearchCenterandtheComparativeandExperimental
Centerforproviding the neededspacesfortheexperimentsof this
stud y.
CONFLICT OF INTEREST
Theauthorshavedeclaredthatnocompetinginterestsexist.
ORCID
Davood Mehrabani https://orcid.org/0000‐0002‐5738‐1719
Seyedeh‐Sara Hashemi https://orcid.org/0000‐0002‐9395‐9573
REFERENCES
1. World Health Organization. 2016 Burns fact sheet worldwide.
2017;2:9. http://www.who.int/mediacentre/factsheets/fs365/en
Accessed6March2018.
 2. FranckCL,SenegagliaAC,LeiteL,deMouraS,FranciscoNF,Ribas
FilhoJM.Influenceofadiposetissue‐derivedstemcellsontheburn
woundhealingprocess.Stem Cells Int.2019;2019:2340725.
    
|
 7
NAZEMP OUR Et A l.
3. Rowan MP, Cancio LC , Elster EA , et al. Bur n wound healin g and
treatment:reviewandadvancements.Crit Care.2015;19:243.
 4. Halim AS, Khoo TL, Yussof M. Biologic and synthetic skin substi‐
tutes:anoverview.Indian J Plast Surg.2010;4 3:S23‐S28.
5. Middelkoop E, van den Bogaerdt AJ, Lamme EN, Hoekstra MJ,
BrandsmaK,Ulrich MM.Porcine woundmodels for skin substitu‐
tionandburntreatment.Biomaterials.2004;25:1559‐1567.
6. Mohtasham Amiri Z, Tanideh N, Seddighi A, et al. The effect
of lithospermum officinale, silver sulfadiazine and alpha oint
ments inhealingofburn wound injuries in rat. World J Plast Surg.
2017;6:313‐318.
7. Sedighi A , Mehrabani D, Shirazi R . Histopathological evalua‐
tion of the healingef fects ofhuman amniotic membrane trans
planta tion in third‐ degree bur n wound injur ies. Comp Clin Pathol.
2016;25:381‐385.
8. Mehrab ani D, Rabiee M, Tamadon A , et al. The growth kinetic,
differentiation properties, karyotyping, and characterization of
adipose tissue‐derived stem cells in hamster. Comp Clin Pathol.
2016;25:1017‐1022.
9. Iravani K, Sobhanmanesh A, Ashraf MJ, Hashemi SB, Mehrabani
D,ZareS .Thehealing ef fect of conditioned mediaandbone mar‐
row‐derivedstemcellsinlaryngotrachealstenosis:acomparisonin
experimentaldogmodel.World J Plast Surg.2 017;6:190‐197.
10. Mehrabani D, Khodakaram‐Tafti A , Shater zadeh‐Yazdi H, Zamiri
B, Omidi M . Comparison of the regenerative ef fect of adipose
derived stem cells, fibrin glue sc affold, and autologous bone
graftin experimental mandibular defectinrabbit.Dent Traumatol.
2018;34:413‐420.
11. Mehrabani D, Mahdiyar P, Torabi K, et al. G rowth kinetics and
characterization of human dental pulp stem cells: comparison
between third molar and f irst premolar teeth. J Clin Exp D ent.
2017;9 :e172‐e177.
12. Mehrabani D, Mehrabani G, Zare S, Manafi A. Adipose‐derived
stemcells(ADSC)andaestheticsurger y:aminireview.World J Plas t
Surg.2013;2:65‐70.
13. Hu ang L, Burd A . An update review of s tem cell applic ations in
burnsandwoundcare.Indian J Plast Surg.2012;45:229‐236.
14. Ko ng CM, Lin HD, Bi swas A, B ongso A , Fong CY. Manufac turing
of human Wh arton's jelly s tem cells for cli nical use: se lection of
serumisimportant.Cytotherapy.2019;21(4):483‐ 495.[Epub ahead
ofprint].
15. HanY,SunT,HanY,etal.Humanumbilicalcordmesenchy malstem
cellsimplantationacceleratescutaneouswoundhealingindiabetic
ratsviatheWntsignalingpathway.Eur J Med Res. 2019;24:10.
16. Khodakaram‐TaftiA ,MehrabaniD,Shaterzadeh‐YazdiH, ZamiriB,
OmidiM.Tissueengineeringinmaxillarybonedefects .World J Plast
Surg.2018;7:3‐11.
17. ZhangCP,FuXB. Therapeuticpotential ofstemcellsin skin repair
andregeneration.Chin J Traumatol.2008;11:209‐221.
18. NamnoumJD.Expander/implantreconstructionwithalloderm:re
centexperience.Plast Reconstr Surg.2009;124:387‐394.
19. Lai C, Song G, Zhao B, et al. Preparation and charac terization
of human sc ar acellular dermal matrix. J Biomater Sci Polym Ed.
2019;30:769‐78 4.[Epubaheadofprint]).
20. Wainwright DJ. Use of an acellular allograft dermal mat rix
(AlloDerm) in the management of full‐thickness burns. Burns.
1995;21:243 ‐248.
21. Shumakov VI, Onishchenko NA, Rasulov MF, Krasheninnikov ME,
Zaiden ov VA. Mesen chymal bone m arrow stem ce lls more ef fec‐
tivelystimulateregener ationofdeepburnwoundsthanembr yonic
fibroblasts.Bull E xp Biol Med.2 00 3;136:19 2‐195.
22. Im am RA , Rizk AA . Effic acy of er ythrop oietin pre treated me sen‐
chymal stem cellsin murine burnwound healing: possible in vivo
transdifferentiationintokeratinocytes.Folia Morphol (Warsz). 2019.
[Epubaheadofprint].
23. FDA .proposedapproachtoregulationofcellularandtissue‐based
products. http://www.fda.gov/downloads/Biologi‐casBloodVa
c c i n e s / G u i d a n c e C o m p l i a n c e R e ‐ g u l a t o r y I n f o r m a t i o n / G u i d a n c e s /
Tissue/UCM‐ 062601.Accessedon26July,2011.
24. K arimi H, So udmand A , Orouj i Z, Taghiabadi E , Mousavi S J. Burn
wound healing with injection of adipose‐derived s tem cells: a
mousemodelstudy.Ann Burns Fire Disasters.2014;27:44 ‐49.
25. ChangYW,WuYC,HuangSH,WangH,KuoYR,LeeSS.Autologous
andnot allogeneic adipose‐derived stemcellsimprove acuteburn
woundhealing.PLoS One.2018;13:e0197744.
26. Fra ncis E, Kear ney L, Clove r J. The effe cts of ste m cells on bur n
wounds:areview.Int J Burns Trauma.2019;9(1):1‐12.eCollection.
27. OrbayH,Takami Y,Hyakusoku H,Mizuno H. Acellulardermal ma‐
trixseededwith adipose‐derivedstemcellsasasubcutaneousim‐
plant.Aesth Plast Surg.2011;35:756‐763.
28. YangY,ZhangW,LiY,FangG,ZhangK.Scaldedskinofrattreated
byusingfibringluecombinedwithallogeneicbonemar rowmesen‐
chymalstemcells.Ann Dermatol.2014;26:289‐295.
29. NambuM,IshiharaM,NakamuraS,etal.Enhancedhealingofmito‐
mycinC‐treatedwoundsinratsusinginbredadiposetissue‐derived
stroma l cells withi n an atelocol lagen matr ix. Wound Repair Regen.
20 07;15:50 5‐510 .
30. MotamedS, Taghiabadi E, Molaei H, et al. Cell‐based skin substi‐
tutesaccelerateregenerationofextensiveburnwoundsinrats.Am
J Surg. 20 17; 214 :762‐769.
31. YanG,SunH, WangF,et al.TopicalapplicationofhPDG F‐A‐mod‐
ified po rcine BMSC and keratinoc ytes loaded on acellul ar HAM
promote s the heali ng of combin ed radiat ion‐wound sk in injur y in
minipigs.Int J Radiat Biol.2011;87:591‐600.
32. G hieh F,J urjus R, Ib rahim A , et al. The use of s tem cells in bu rn
woundhealing:areview.Biomed Res Int. 2015;2015:684084.
33. FoubertP,BarillasS,GonzalezAD,etal.Unculturedadipose‐derived
regenerative cells (ADRCs) seeded incollagen scaffold improves
dermalregeneration,enhancingearlyvascularizationandstructural
organizationfollowingthermalburns.Burns.2015;41:1504‐1516.
34. Chen Y‐W,Scutar uTT,G hetu N, et al. Theeffects of adipose‐de‐
rivedstemcell‐differentiatedadipocytesonskinburnwoundheal
inginrats.J Burn Care Res.2017;38:1‐10.
35. SingerDD,SingerAJ,G ordonC,Br inkP.Theef fect sofratmesen‐
chymalstemcellsoninjuryprogressioninar atmodel.Acad Emerg
Med.2013;20:398‐402.
36. Liu P, Deng Z, Han S, et al. Tissue‐engineered skin containing
mesenchymal stem cells improves burn wounds . Artif Organs.
2008;32:925‐931.
37. Cr uz FF,Ro cco P.Stem‐ cell extr acellula r vesicles an d lung repa ir.
Stem Cell Investig. 2017;4:78.
38. LiuL ,YuY,HouY,etal.Humanumbilicalcordmesenchymals tem
cellstransplantationpromotescutaneouswoundhealingofsevere
burnedr ats.PLoS One.2014;9:e8 8348.
39. Cl over AJP, Kumar AHS, Is akson M, et al . Allogeneic me senchy‐
mals temcells, but not culturemo difiedmonocy tes, improveburn
woundhealing.Burns.2015;41:548‐557.
How to cite this article:NazempourM,MehrabaniD,
Mehdinavaz‐AghdamR ,etal.Theeffectofallogenichuman
Wharton'sjellystemcellsseededontoacellulardermal
matrixinhealingofratburnwounds.J Cosmet Dermatol.
2019;00:1–7. https://doi.or g/10.1111/jo cd .1310 9
... The beneficial effects of MSCs from various sources, including Wharton's jelly, have been indicated in various experimental and animal studies [29,30]. Nazempour and colleagues also reported that the use of allogeneic WJ-MSCs induced the healing of burn injuries in animal models [31]. ...
... This may show the better healing process of our construct in wound healing. However, we used animals with full-thickness skin defects, while Nazempour et al., used animals with burn injuries, making it difficult to compare the results of the studies [31]. Meanwhile, both studies indicated the potential of xenograft ADM in combination with MSCs in skin regeneration. ...
... However, it should be noted that the healing process of wounds in rats differs from human wounds. While in humans, the healing is based on re-epithelialization, in rats, the healing is also based on contraction mediated by panniculuscarnosus, which is removed through skin debridement [31]. In addition, the optimal number of MSCs required for skin regeneration was small (2 × 10 6 cells for each matrix), which cannot be generalized to human patients. ...
Article
Full-text available
The treatment of full-thickness skin wounds is a problem in the clinical setting, as they do not heal spontaneously. Extensive pain at the donor site and a lack of skin grafts limit autogenic and allogeneic skin graft availability. We evaluated fetal bovine acellular dermal matrix (FADM) in combination with human Wharton’s jelly mesenchymal stem cells (hWJ-MSCs) to heal full-thickness skin wounds. FADM was prepared from a 6-month-old trauma-aborted fetus. WJ-MSCs were derived from a human umbilical cord and seeded on the FADM. Rat models of full-thickness wounds were created and divided into three groups: control (no treatment), FADM, and FADM-WJMSCs groups. Wound treatment was evaluated microscopically and histologically on days 7, 14, and 21 post-surgery. The prepared FADM was porous and decellularized with a normal range of residual DNA. WJ-MSCs were seeded and proliferated on FADM effectively. The highest wound closure rate was observed in the FADM-WJMSC group on days 7 and 14 post-surgery. Furthermore, this group had fewer inflammatory cells than other groups. Finally, in this study, we observed that, without using the differential cell culture media of fibroblasts, the xenogeneic hWJSCs in combination with FADM could promote an increased rate of full-thickness skin wound closure with less inflammation.
... ADM can be especially useful in the augmentation of tendon repair. [12][13][14] ADMs can, in addition to mechanical tendon support, improve the healing process by revascularization, cellular growth, and reepithelialization in hosts. [15][16][17][18] The mechanical support the ADM provides reduces the risk of reinjury and adhesion of the tendon in repair procedures. ...
... [32][33][34] This graft is ideal for tissue healing because it not only provides a proper environment for fibroblast cells to multiply and migrate but also does not trigger the patient's immune system due to its cell-free nature. 12,35 With the existence of collagen types I and III, elastin fibers, glycosaminoglycans (GAGs), glycoproteins (GPs), proteoglycans (PGs), fibronectin, fibrin, heparin, and integrin, this product is ideal for connecting, proliferating, and migrating skin cells. [36][37][38] Hence, we investigated the physical and chemical characteristics of ADM/ZnO-NPs, including tensile strength, morphology, viability, and antibacterial characteristics. ...
Article
Full-text available
Introduction: Flexor tendon injuries are common and require surgery. Acellular dermal matrix (ADM) is a natural graft used to repair tissues, though infections represent the primary cause of its therapeutic failure. In this study, zinc oxide nanoparticles (ZnO-NPs) were coated on the ADM in order to add antibacterial potential as well as enhance healing properties. Also, the produced ADM/ZnO-NPs graft was applied to accelerate fifth zone flexor tendon repair following the reconstructive surgery. Methods: Morphological, mechanical, cell viability, and antibacterial tests were performed to evaluate the physical and biological properties of the fabricated ADM/ZnO-NPs graft. For clinical evaluations, 20 patients with a flexor tendon injury in zone 5 were randomly divided into control and treatment with ADM/ZnO-NPs groups (n=10 each). The control group had routine reconstructive surgery, while the other group received the ADM/ZnO- NPs graft during their surgery. Postoperative functional outcomes were evaluated 4, 6, and 8 weeks following the tendon repair surgery according to the Buck-Gramcko II criteria. Results: The ADM/ZnO-NPs had natural derm specifications as well as dense and integrated morphology with intermediate antibacterial properties. According to the Buck- Gramcko II criteria, the postoperative functional outcome scores were significantly higher in the ADM/ZnO-NPs group in comparison with the control group at 4 (P<0.01), 6 (P<0.01), and 8 (P<0.001) weeks after the surgery. Conclusion: The present findings revealed that the ADM/ZnO-NPs graft can accelerate the healing of the damaged tendon without common post-operative functional complications and adhesions following the tendon repair surgery. However, more comprehensive clinical trials are still needed.
... In this regard, mesenchymal stem cells (MSCs) have been considered operative components of scaffolds for supporting angiogenesis, modulating immune responses, and reducing scar formation during the skin burn healing process [12,13]. The human umbilical cord's Wharton's jelly is a pivotal source of MSCs [14]. ...
... Several studies have highlighted that the combination of cell therapy with burn tissue engineering resulted in faster and superior wound healing [42]. Almost the application of MSC in cell therapy-based burn care confirmed its high efficacy in immune regulation, angiogenesis, and granulation tissue formation in skin burn injuries [13]. Furthermore, ease of sourcing and immune-escaping capacities are some of the significant transplantable features of hWJ-derived MSCs [15]. ...
Article
Full-text available
Burn wounds are the most destructive and complicated type of skin or underlying soft tissue injury that are exacerbated by a prolonged inflammatory response. Several cell-based therapeutic systems through the culturing of potent stem cells on modified scaffolds have been developed to direct the burn healing challenges. In this context, a new regenerative platform based on boron (B) enriched-acellular sheep small intestine submucosa (AOSIS) scaffold was designed and used as a carrier for mesenchymal stem cells derived from Wharton's jelly (WJMSCs) aiming to promote the tissue healing in burn-induced rat models. hWJMSCs have been extracted from human extra-embryonic umbilical cord tissue. Thereafter, 96 third‐degree burned Wistar male rats were divided into 4 groups. The animals that did not receive any treatment were considered as group A (control). Then, group B was treated just by AOSIS scaffold, group C was received cell-seeded AOSIS scaffold (hWJMSCs-AOSIS), and group D was covered by boron enriched-cell-AOSIS scaffold (B/hWJMSCs-AOSIS). Inflammatory factors, histopathological parameters, and the expression levels of epitheliogenic and angiogenic proteins were assessed on 5, 14 and 21 days post-wounding. Application of the B/hWJMSCs-AOSIS on full-thickness skin-burned wounds significantly reduced the volume of neutrophils and lymphocytes at day 21 post-burning, whilst the number of fibroblasts and blood vessels enhanced at this time. In addition, molecular and histological analysis of wounds over time further verified that the addition of boron promoted wound healing, with decreased inflammatory factors, stimulated vascularization, accelerated re-epithelialization, and enhanced expression levels of epitheliogenic genes. In addition, the boron incorporation amplified wound closure via increasing collagen deposition and fibroblast volume and activity. Therefore, this newly fabricated hWJMSCs/B-loaded scaffold can be used as a promising system to accelerate burn wound reconstruction through inflammatory regulation and angiogenesis stimulation.
... MSCs have been derived from various tissues including adipose tissue (15), bone marrow (16), Wharton's jelly (17), amniotic membrane (18), endometrium (19), menstrual blood (20), periodontal ligaments (21) and dental pulp (22), that possesses anti-inflammatory and immunomodulating properties (23). They are easily cultivated and have been used in clinical trials (24). ...
Article
Background: Methamphetamine use can provide a quick and pleasurable rush, increased energy, heightened attention, and euphoria, but may also result in many adverse effects. Various cell lines have been utilized in vitro to determine the adverse impacts of methamphetamine on those cells. As enough data are not available on the effect of methamphetamine on skin fibroblast cells, this study determined its in vitro effect on proliferation, differentiation and apoptosis of human skin fibroblast cells. Methods: Phenotypic characteristics of fibroblasts cells were determined and real-time PCR examined the expression of matrix metalloproteinase1 (MMP1), matrix metalloproteinase 3 (MMP3), integrin alpha 11 (ITGA11), CD106, CD10, and CD26 markers. MTT assay checked the toxicity of recreational doses of 6 and 60 µM of methamphetamine. Quantitative real time polymerase chain reaction (qPCR) assessed expression of Bax, Bcl-2 and PPARγ genes. Results: Fibroblast cells were morphologically spindle-shape and were positive for fibroblast markers of CD10, CD26, MMP1 and MMP3 and negative for mesenchymal markers of ITGA11 and CD106. MTT assay revealed a decline in proliferation of fibroblast cells when they were exposed to methamphetamine. The expression of Bax and PPARγ genes increased and decreased for Bcl-2 gene after exposure of cells to methamphetamine. Conclusion: Our results confirmed adverse effects of methamphetamine on proliferation, viability and differentiation of skin fibroblast cells revealing a reduction in cell proliferation and differentiation as well as an increase in cell apoptosis. These findings can open a window to health status of people who target methamphetamine use for recreational purposes.
... Due to limited sources of donor skin grafts, tissue-engineered skin substitutes present an efficient solution. Skin substitutes have been considered as an alternative to animal models for testing in the cosmetic and pharmaceutical industries (Nazempour et al., 2020). ...
... MSCs have been derived from various tissues including adipose tissue (15), bone marrow (16), Wharton's jelly (17), amniotic membrane (18), endometrium (19), menstrual blood (20), periodontal ligaments (21) and dental pulp (22), that possesses anti-inflammatory and immunomodulating properties (23). They are easily cultivated and have been used in clinical trials (24). ...
Article
Full-text available
Background: Cannabis, commonly known as marijuana, is widely used for recreational purposes. It has stimulatory effect on appetite, so cannabinoid receptor antagonists have been used to decrease food intake and to act peripherally by rising thermogenesis and energy expenditure to control obesity. This in vitro study determined morphological, growth, apoptosis and differential potential of changes in dental pulp stem cells (DPSCs) when marijuana was added to nutrients of cell culture medium. Methods: Wisdom teeth extracted were used to obtain DPSCs, while characterized morphologically, by osteo-and adipo-inductions and flowcytometry for mesenchymal properties. MTT assay identified optimal concentration of cannabis extract. Cells were treated with 120 and 1000 ng/mL of cannabis during seven days period, while proliferation, apoptosis and differentiation of DPSCs were assessed. Results: DPSCs were spindle shape and showed mesenchymal characteristics. MTT assay illustrated an increase in cell number until day 5 th when DPSCs were treated with 120 and 1000 ng/mL of cannabis, while there was a decreasing trend on day 6 th. There was an upregulation of the expression of Bax and COL1A1genes on day 6 th when 120 and 1000 ng/mL of cannabis were added to the media in comparison to the control group. Conclusion: The increase in DPSC proliferation and viability when treated with cannabis denotes to its positive impact on cell proliferation during short term period, while a long term exposure to cannabis resulted in apoptosis and a decrease in cell proliferation. These findings reveal an issue of public health concern and alarm for health authorities.
... Treatment of burn wounds is one of the most clinical problems and the application of the most effective burn repair methods is still a continuous challenge in medicine [20]. Despite several chemical products utilized to treat burn wounds, worldwide interest is growing in natural products and traditional medicine [21]. ...
Article
Full-text available
Tissue engineering application in otology spans a distance from the pinna to auditory nerve covered with specialized tissues and functions such as sense of hearing and aesthetics. It holds the potential to address the barriers of lack of donor tissue, poor tissue match, and transplant rejection through provision of new and healthy tissues similar to the host and possesses the capacity to renew, to regenerate, and to repair in-vivo and was shown to be a bypasses for any need to immunosuppression. This review aims to investigate the application of tissue engineering in otology and to evaluate the achievements and challenges in external, middle and inner ear sections. Since gaining the recent knowledge and training on use of different scaffolds is essential for otology specialists and who look for the recovery of ear function and aesthetics of patients, it is shown in this review how utilizing tissue engineering and cell transplantation, regenerative medicine can provide advancements in hearing and ear aesthetics to fit different patients’ needs.
Article
Electrospun nanofibrous mats have shown great potential for dressing skin wounds. In this study, a nanofibrous mat composed of polycaprolactone (PCL), Gelatin (GLT), and Lucilia sericata larva extract (LSLE) was fabricated by the electrospinning method. The morphology of the fabricated nanofibrous mat and its morphological properties (fibers distribution frequency, fiber diameter, pore area, number of pores, and intersection density) were evaluated by scanning electron microscopy (SEM) and ImageJ software. The PCL/GLT/LSLE nanofibrous mat had well-branched and porous structure with a mean diameter of 500.2 ± 20.46. The presence of functional groups of PCL and GLT polymers in the structure of the PCL/GLT/LSLE mat was confirmed by Fourier-transform infrared spectroscopy (FTIR). Contact angle measurement and swelling behavior assessment showed that the PCL/GLT/LSLE mat had better surface wettability (75.67 ± 2.71) and hydrophilicity (241.8 ± 27.01) properties in comparison with the PCL and PCL/GLT mats. Findings from the MTT assay indicated the biocompatibility of the PCL/GLT/LSLE mat for human dermal fibroblasts (HDFs). In addition, the anchorage and proliferation of HDFs on the PCL/GLT/LSLE mat was confirmed by SEM. Macroscopic and histopathological evaluations were performed at the end of the 3, 7, and 14 days after the conduction of experimental burn wound injury in rats. The results indicated that grafting the skin wounds with the PCL/GLT/LSLE nanofibrous mat accelerated the wound closure and improved histopathological score compared to the other animal groups dressed with the PCL and PCL/GLT mats. In conclusion, the PCL/GLT/LSLE nanofibrous mat has promising potential for dressing skin wounds.
Article
Full-text available
Introduction: Stem cell therapy application is at the vanguard of regenerative medicine across all medical disciplines. Stem cells are of special interest in burn wounds, as they have multiple potential indications for application; including - accelerating wound healing, improving skin regeneration to incorporate skin appendages, reducing fibrosis and improving scarring. Methods: A literature review was performed using both MeSH and keyword searches of PubMed to identify all potentially suitable publications. Search criteria were restricted to the English language, but acceptable English translations were sought for inclusion. Inclusion dates were from 2003 up until and including 2017. Studies included looked at stem cells in burn wounds only. Results: There were 692 potentially suitable publications of which 72 were included for review. These included a systematic reviews and original research articles. Conclusions: Stem cells accelerate burn wound healing by inducing neo-angiogenesis, collagen deposition and granulation tissue formation. They modulate the inflammatory response and reduce the risk of infection. They can regenerate skin appendages and halt he zone of stasis in acute burn injury. However with these pre-clinical animal model studies we must be cautious with our interpretation of this novel therapy.
Article
Full-text available
Background: Stem cells have shown promising potential to treat burn wounds. Erythropoietin was capable of promoting in vitro transdifferentiation of mesenchymal stem cells (MSCs). The aim of the study was to investigate the possible role of erythropoietin pretreated mesenchymal stem cells (EPOa/MSCs) in burn wounds healing and to evaluate its in vivo differentiation into keratinocytes. Materials and Methods: Forty rats were utilized in this study divided into 4 groups (n=10 for each). Control group (I), Burn group (II), Burn + MSCs, group (III), Burn + EPOa/MSCs. 1x106 Cells were injected locally for every 1 cm2 of burn areas. Burn areas were followed morphologically. After 21days of the experiment, the rats were euthanized, skin specimens were assessed biochemically, histologically and immunohistochemically. Results: EPOa/MSCs had enhanced significantly (p<0.05) burn wound vimentin gene expression and level of IL-10 while decreased IL-1 and COX2 as compared to the burn group. Histologically, EPOa/MSCs had improved epithelialization despite stem cells differentiation into keratinocytes had been rarely detected by PKH26 red fluorescence. EPOa/MSCs had promoted angiogenesis as detected by a significant increase in VEGF and PDGF immunoexpression as compared to burn group. Conclusions: EPOa/MSCs might improve burn wound healing probably through anti-inflammatory, immunomodulatory and angiogenic action. However, in vivo transdifferentiation into keratinocytes had been rarely detected.
Article
Full-text available
Burns are lesions in which the thermal energy of the causative agent transfers heat to the surface of the body, causing superficial or deep damage to the skin with protein denaturation in cells and biochemical maladjustments, which delay and disrupt the cicatricial process, increasing the chances of functional and aesthetic sequelae. This study evaluates the influence of adipose tissue-derived stem cells (ADSCs) on burn healing in terms of the size of the cicatricial space and quantified measures of collagen deposition, inflammatory infiltrate, blood vessels, and lymphatic vessels. Initially, intra-abdominal adipose tissue was resected from a single donor Wistar rat that was not part of any of the subsequent groups to obtain ADSCs by isolation and cell culture. Burns were made in the left lateral abdominal region of Wistar rats by contact with a square ceramic paper with a 484 mm ² area heated to 100°C for 30 seconds. Intradermal ADSC transplantation was performed in two stages. The first was on the same day of the burn, when 3.2×106 ADSCs were transplanted shortly after the burned region cooled, while the second stage occurred four days later with the same number of ADSCs. The progress was evaluated by immunohistochemical methods and H&E, Masson’s trichrome, Picrosirius red, and Lyve-1 immunofluorescence staining. Despite the quantitative similarity of blood vessels and the inflammatory infiltrate observed by H&E, there were statistically significant differences between the groups on the fourteenth day of evolution. The group that received ADSCs showed a reduction in the scar tissue area, increased collagen type III deposition, and a quantifiable reduction in lymphatic vessels, so we conclude that ADSCs influence the healing of total thickness burns in rats.
Article
Full-text available
Objective Difficulty in wound healing is one common complication of diabetes mellitus. The study explored whether the therapeutic effect of human umbilical cord mesenchymal stem cells (hUCMSCs) on diabetic ulcer wound was enhanced by the activation of the Wnt signaling pathway. Methods Rat diabetic model was established by intraperitoneal injection of Streptozotocin (STZ). hUCMSCs were purified and seeded on the collagen–chitosan laser drilling acellular dermal matrix (CCLDADM) scaffold, which was subsequently implanted into the cutaneous wound of normal and diabetic rats, followed by daily injection of Wnt signaling pathway agonist (Wnt3a) or antagonist (sFRP3) at the edge of the scaffold. Wound healing was checked on days 7, 14, and 21, and the fibrous tissue deposition, capillaries, and epidermal regeneration at the wound were examined by hematoxylin–eosin staining. The hUCMSCs-CCLDADM scaffold was cultured in vitro and treated with Wnt3a or sFRP3, followed by evaluation of cell proliferation, cell proliferation rate, survival status, and altered protein levels in the Wnt signaling pathway using BrdU staining, CCK-8 assay, live/dead staining, and Western blotting, respectively. Results On days 7 and 14 postoperatively, the speed of wound healing was significantly lower in diabetic rats than that in normal control rats. This phenomenon was significantly improved by the activation of the Wnt signaling pathway that also elevated the fibrous protein deposition and the abundance of capillary in the granulation tissue. Conversely, blockade of Wnt signaling slowed the healing of skin wound in diabetic rats. The activation of Wnt signaling pathway promoted the proliferation and differentiation and decreased the apoptosis of hUCMSCs, thereby elevating the number of living hUCMSCs on the CCLDADM scaffold, while the suppression exerted a contrary effect. Conclusion The activation of the Wnt signaling pathway promotes the healing of diabetic skin wound by the regulation of proliferation and differentiation of hUCMSCs on the CCLDADM scaffold.
Article
Full-text available
Adipose-derived stem cells (ADSCs) transplant has been reported to be a potential treatment for burn wounds. However, the effects of autogenicity and allogenicity of ADSCs on burn wound healing have not been investigated and the method for using ADSCs still needs to be established. This study compared the healing effects of autologous and allogenic ADSCs and determined an optimal method of using ADSCs to treat acute burn wounds. Experiments were performed in 20 male Wistar rats (weight, 176–250 g; age, 6–7 weeks). Two identical full-thickness burn wounds (radius, 4 mm) were created in each rat. ADSCs harvested from inguinal area and characterized by their high multipotency were injected into burn wounds in the original donor rats (autologous ADSCs group) or in other rats (allogenic ADSCs group). The injection site was either the wound center or the four corners 0.5 cm from the wound edge. The reduction of burn surface areas in the two experimental groups and in control group were evaluated with Image J software for 15 days post-wounding to determine the wound healing rates. Wound healing was significantly faster in the autologous ADSCs group compared to both the allogenic ADSCs group (p<0.05) and control group (p<0.05). Wound healing in the allogenic ADSC group did not significantly differ from that in control group. Notably, ADSC injections 0.5cm from the wound edge showed significantly improved healing compared to ADSCs injections in the wound center (p<0.05). This study demonstrated the therapeutic efficacy of ADSCs in treating acute burn wounds in rats. However, only autologous ADSCs improved healing in acute burn wounds; allogenic ADSCs did not. This study further determined a superior location of using ADSCs injections to treat burn wounds including the injection site. Future studies will replicate the experiment in a larger and long-term scale burn wounds in higher mammalian models to facilitate ADSCs therapy in burn wound clinical practice.
Article
Full-text available
Background: Restoration of craniofacial bone defects has been a concern for oral and maxillofacial surgeons. In this study, the healing effect of fibrin glue scaffold was compared with autologous bone graft in mandibular defects of rabbit. Methods: Bilateral unicortical osteotomy was performed in the diastema region of 10 male Dutch rabbits. The subjects were randomly divided into 2 equal groups. The mandibular defect on the right side was treated with fibrin glue scaffold and the defect on the left side with autologous bone graft provided from iliac crest. After 4 and 8 weeks, five rabbits from each group were sacrificed and the defects were evaluated morphologically, by coronal computed tomography scanning (CT-scan) and by histological examinations. Results: The healing effect of fibrin glue scaffold and autologous bone graft was similar with appropriate osteogenesis in comparison to the control group. Conclusion: Using fibrin glue can be a non-invasive treatment of choice in mandibular defects and maxillofacial surgeries when compared with autologous bone graft.
Article
Introduction: Acellular dermal matrix (ADM) is commonly used to treat burn injuries and wounds. In this study, we aimed to analyze the structural and biomechanical characteristics of an ADM from human scars. Methods: We randomly selected human mature scars, human proliferative scars, and human normal skin as experimental specimens. Split-thickness dermal grafts were obtained using a free-hand graft knife. Samples were subjected to cell lysis to obtain ADMs. Structural analysis was performed via light microscopy, fluorescence microplate reader and scanning electron microscopy. Thereafter, human epithelial stem cells were incubated on these ADMs. Finally, the biomechanical characteristics of the ADMs were analyzed using a tensile machine. Results: Normal skin ADM fibers were arranged in order, whereas proliferative scar ADM fibers were dense and disordered, and mature scar ADM fibers were porous and slightly disordered. The residual DNA of three ADM meet the residual DNA standard of biological material. After incubating human epithelial stem cells on ADMs, cells grew in an aggregated state in both normal skin ADMs and mature scar ADMs; however, cells adhered only on the surface of proliferative scar ADMs. No significant differences were observed in the Young’s modulus, relaxation slope, creep slope, creep, or maximum tensile stress among the three ADMs, although significant differences in stress-strain elongation and relaxation were noted. Conclusions: Our findings showed that mature scar ADMs were similar to proliferative scar ADMs, showing a slight lag compared with normal skin ADMs, providing insights into the biomechanical features of these scar tissues.
Article
Background: Stem cells have shown promising potential to treat burn wounds. Erythropoietin was capable of promoting in vitro transdifferentiation of mesenchymal stem cells (MSCs). The aim of the study was to investigate possible role of erythropoietin-pretreated mesenchymal stem cells (EPOa/MSCs) in burn wounds healing and to evaluate its in vivo differentiation into keratinocytes. Materials and methods: Forty rats were utilised in this study divided into four groups (n = 10 for each). Control group (I), burn group (II), burn + MSCs, group (III), burn + EPOa/MSCs. 1 × 10⁶ cells were injected locally for each 1 cm² of burn areas. Burn areas were followed-up morphologically. After 21 days of the experiment, the rats were euthanised, skin specimens were assessed biochemically, histologically and immunohistochemically. Results: EPOa/MSCs enhanced significantly (p < 0.05) burn wound vimentin gene expression and level of interleukin (IL)-10 while decreased IL-1 and COX2 as compared to the burn group. Histologically, EPOa/MSCs improved epithelialisation despite stem cells' differentiation into keratinocytes was rarely detected by PKH26 red fluorescence. EPOa/MSCs promoted angiogenesis as detected by significant increase in VEGF and PDGF immunoexpression as compared to burn group. Conclusions: EPOa/MSCs may improve burn wound healing, probably through anti-inflammatory, immunomodulatory and angiogenic action. However, in vivo transdifferentiation into keratinocytes was rarely detected.
Article
Background: Human Wharton's jelly-derived mesenchymal stromal cells (hWJSCs) have gained considerable attention for their use in cell therapy. Many of these applications would require manufacturing of millions of hWJSCs. It is, therefore, necessary to develop a Good Manufacturing Practice (GMP)-compliant hWJSC expansion protocol, allowing the generation of a large quantity of cells to meet both clinical and regulatory requirements. Here, we compared human platelet lysate (HPL) and human serum (HS) in supporting clinical-grade hWJSC expansion. Methods: hWJSCs were successfully isolated from six different umbilical cords using GMP-compliant dissociation enzymes. Freshly isolated hWJSCs were cultured in media supplemented with 10% of one of the following sera: fetal bovine serum (FBS), HPL and HS. Properties of the expanded hWJSCs were analyzed. Results: We showed that GMP-compliant dissociation enzymes were as efficient as research-grade dissociation enzymes in isolating hWJSCs. hWJSC fresh cell yield and cell viability using HPL and HS supplementations were at greater advantages than FBS. Moreover, hWJSCs expanded in HPL and HS supplementations not only preserved classical MSCs phenotypes and differentiation potential to adipocytes, osteocytes and chondrocytes, they also enhanced the migration of skin fibroblasts. However, HS, unlike HPL, did not alter immunogenicity properties of hWJSCs. hWJSCs expanded in HS supplementation also exerted greater immunosuppressive action in inhibiting T-cell proliferation and increased extracellular matrix (ECM) gene expression, making them useful in tissue repair clinical application. Conclusion: Our findings indicate that HS can be considered as a promising and safer alternative to FBS, and should be recommended for clinical-grade expansion of hWJSCs.
Article
Background/Aims One of the main concerns for maxillofacial and orthopedic surgeons is finding a method to improve regeneration of large craniofacial bone defects. The aim of this study was to investigate the healing and regenerative effects of fibrin glue associated with adipose‐derived stem cells (ADSCs) and fibrin glue scaffold alone with autologous bone grafts in experimental mandibular defects of the rabbit. Methods Bilateral uni‐cortical osteotomies were performed in the mandible of 20 male Dutch rabbits. The animals were randomly divided into 2 equal groups. In one group, the defect on the right side was treated by fibrin glue associated with ADSCs and the defect on the other side remained as the control. In another group, the defect on the right side was treated with fibrin glue and on the left side with autologous bone graft. After 28 and 56 days, five rabbits from each group were evaluated by computed tomography (CT) and histopathological examinations. Results Coronal CT showed a remarkable reconstruction of cortical bone in the fibrin glue associated with ADSCs group at 28 and 56 days post‐surgery. Histopathologically, new cortical bony bridge formation was seen increasingly in the fibrin glue, fibrin glue associated with ADSCs and autologous bone graft groups after 28 days. Statistical analysis of the thickness of new cortical bone in the treatment versus control groups showed a significant difference between fibrin glue alone and fibrin glue associated with ADSCs groups (P = 0.02). No significant difference was found between the fibrin glue associated with ADSCs and the autologous bone graft groups (P> 0.05). Conclusions The healing process had a significant increase in the thickness of new cortical bone when fibrin glue scaffold associated with ADSCs was used. This article is protected by copyright. All rights reserved.